nodes	percent_of_prediction	percent_of_DWPC	metapath
Capecitabine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0674	0.126	CbGbCtD
Capecitabine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0634	0.119	CbGbCtD
Capecitabine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0634	0.119	CbGbCtD
Capecitabine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0573	0.107	CbGbCtD
Capecitabine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0573	0.107	CbGbCtD
Capecitabine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0495	0.0925	CbGbCtD
Capecitabine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.048	0.0898	CbGbCtD
Capecitabine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0434	0.0812	CbGbCtD
Capecitabine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0434	0.0812	CbGbCtD
Capecitabine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0416	0.0779	CbGbCtD
Capecitabine—TYMP—endothelium—acquired immunodeficiency syndrome	0.00599	0.0664	CbGeAlD
Capecitabine—TYMP—blood plasma—acquired immunodeficiency syndrome	0.00532	0.059	CbGeAlD
Capecitabine—CDA—lymphoid tissue—acquired immunodeficiency syndrome	0.00344	0.0381	CbGeAlD
Capecitabine—DPYD—blood—acquired immunodeficiency syndrome	0.00336	0.0373	CbGeAlD
Capecitabine—DPYD—bone marrow—acquired immunodeficiency syndrome	0.00326	0.0361	CbGeAlD
Capecitabine—CDA—blood—acquired immunodeficiency syndrome	0.00324	0.0359	CbGeAlD
Capecitabine—CDA—bone marrow—acquired immunodeficiency syndrome	0.00313	0.0347	CbGeAlD
Capecitabine—CDA—vagina—acquired immunodeficiency syndrome	0.003	0.0332	CbGeAlD
Capecitabine—DPYD—lung—acquired immunodeficiency syndrome	0.00295	0.0327	CbGeAlD
Capecitabine—TYMS—skin of body—acquired immunodeficiency syndrome	0.00219	0.0243	CbGeAlD
Capecitabine—DPYD—brain—acquired immunodeficiency syndrome	0.00209	0.0231	CbGeAlD
Capecitabine—TYMP—lymphoid tissue—acquired immunodeficiency syndrome	0.00207	0.023	CbGeAlD
Capecitabine—TYMP—digestive system—acquired immunodeficiency syndrome	0.00205	0.0227	CbGeAlD
Capecitabine—DPYD—lymph node—acquired immunodeficiency syndrome	0.00202	0.0224	CbGeAlD
Capecitabine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00199	0.0221	CbGeAlD
Capecitabine—TYMP—blood—acquired immunodeficiency syndrome	0.00195	0.0216	CbGeAlD
Capecitabine—CDA—lymph node—acquired immunodeficiency syndrome	0.00194	0.0215	CbGeAlD
Capecitabine—TYMP—bone marrow—acquired immunodeficiency syndrome	0.00189	0.0209	CbGeAlD
Capecitabine—TYMP—spinal cord—acquired immunodeficiency syndrome	0.00188	0.0208	CbGeAlD
Capecitabine—TYMP—vagina—acquired immunodeficiency syndrome	0.00181	0.02	CbGeAlD
Capecitabine—CES1—lymphoid tissue—acquired immunodeficiency syndrome	0.00179	0.0198	CbGeAlD
Capecitabine—TYMS—lymphoid tissue—acquired immunodeficiency syndrome	0.00178	0.0197	CbGeAlD
Capecitabine—CES1—digestive system—acquired immunodeficiency syndrome	0.00177	0.0196	CbGeAlD
Capecitabine—TYMS—digestive system—acquired immunodeficiency syndrome	0.00176	0.0195	CbGeAlD
Capecitabine—TYMP—lung—acquired immunodeficiency syndrome	0.00171	0.0189	CbGeAlD
Capecitabine—CES1—blood—acquired immunodeficiency syndrome	0.00168	0.0186	CbGeAlD
Capecitabine—TYMS—blood—acquired immunodeficiency syndrome	0.00167	0.0185	CbGeAlD
Capecitabine—TYMS—bone marrow—acquired immunodeficiency syndrome	0.00162	0.0179	CbGeAlD
Capecitabine—TYMP—nervous system—acquired immunodeficiency syndrome	0.00158	0.0175	CbGeAlD
Capecitabine—TYMS—vagina—acquired immunodeficiency syndrome	0.00155	0.0172	CbGeAlD
Capecitabine—TYMP—central nervous system—acquired immunodeficiency syndrome	0.00152	0.0169	CbGeAlD
Capecitabine—CES1—lung—acquired immunodeficiency syndrome	0.00148	0.0163	CbGeAlD
Capecitabine—TYMS—lung—acquired immunodeficiency syndrome	0.00147	0.0162	CbGeAlD
Capecitabine—CES1—nervous system—acquired immunodeficiency syndrome	0.00137	0.0151	CbGeAlD
Capecitabine—TYMS—nervous system—acquired immunodeficiency syndrome	0.00136	0.015	CbGeAlD
Capecitabine—CES1—central nervous system—acquired immunodeficiency syndrome	0.00132	0.0146	CbGeAlD
Capecitabine—TYMS—central nervous system—acquired immunodeficiency syndrome	0.00131	0.0145	CbGeAlD
Capecitabine—TYMP—brain—acquired immunodeficiency syndrome	0.00121	0.0134	CbGeAlD
Capecitabine—TYMP—lymph node—acquired immunodeficiency syndrome	0.00117	0.013	CbGeAlD
Capecitabine—CES1—brain—acquired immunodeficiency syndrome	0.00104	0.0116	CbGeAlD
Capecitabine—TYMS—brain—acquired immunodeficiency syndrome	0.00104	0.0115	CbGeAlD
Capecitabine—CES1—lymph node—acquired immunodeficiency syndrome	0.00101	0.0112	CbGeAlD
Capecitabine—TYMS—lymph node—acquired immunodeficiency syndrome	0.001	0.0111	CbGeAlD
Capecitabine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000766	0.00849	CbGeAlD
Capecitabine—CYP2C9—blood—acquired immunodeficiency syndrome	0.00073	0.00809	CbGeAlD
Capecitabine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000109	0.000291	CcSEcCtD
Capecitabine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000291	CcSEcCtD
Capecitabine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000291	CcSEcCtD
Capecitabine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000291	CcSEcCtD
Capecitabine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000291	CcSEcCtD
Capecitabine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000109	0.00029	CcSEcCtD
Capecitabine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.00029	CcSEcCtD
Capecitabine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.00029	CcSEcCtD
Capecitabine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000289	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000289	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000288	CcSEcCtD
Capecitabine—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000287	CcSEcCtD
Capecitabine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000285	CcSEcCtD
Capecitabine—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000107	0.000285	CcSEcCtD
Capecitabine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000107	0.000285	CcSEcCtD
Capecitabine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000107	0.000285	CcSEcCtD
Capecitabine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.000284	CcSEcCtD
Capecitabine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000284	CcSEcCtD
Capecitabine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000283	CcSEcCtD
Capecitabine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000106	0.000283	CcSEcCtD
Capecitabine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000106	0.000283	CcSEcCtD
Capecitabine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000106	0.000283	CcSEcCtD
Capecitabine—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000283	CcSEcCtD
Capecitabine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000106	0.000282	CcSEcCtD
Capecitabine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000106	0.000282	CcSEcCtD
Capecitabine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000282	CcSEcCtD
Capecitabine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000282	CcSEcCtD
Capecitabine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000281	CcSEcCtD
Capecitabine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000281	CcSEcCtD
Capecitabine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.000281	CcSEcCtD
Capecitabine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000105	0.000281	CcSEcCtD
Capecitabine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00028	CcSEcCtD
Capecitabine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00028	CcSEcCtD
Capecitabine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.00028	CcSEcCtD
Capecitabine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000279	CcSEcCtD
Capecitabine—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000279	CcSEcCtD
Capecitabine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000104	0.000278	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000278	CcSEcCtD
Capecitabine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.000277	CcSEcCtD
Capecitabine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000276	CcSEcCtD
Capecitabine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000276	CcSEcCtD
Capecitabine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000275	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000103	0.000275	CcSEcCtD
Capecitabine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000103	0.000274	CcSEcCtD
Capecitabine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.000274	CcSEcCtD
Capecitabine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.000274	CcSEcCtD
Capecitabine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000274	CcSEcCtD
Capecitabine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000103	0.000274	CcSEcCtD
Capecitabine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000273	CcSEcCtD
Capecitabine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000273	CcSEcCtD
Capecitabine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000102	0.000273	CcSEcCtD
Capecitabine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000273	CcSEcCtD
Capecitabine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000102	0.000273	CcSEcCtD
Capecitabine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000272	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000272	CcSEcCtD
Capecitabine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000102	0.000272	CcSEcCtD
Capecitabine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000272	CcSEcCtD
Capecitabine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000102	0.000271	CcSEcCtD
Capecitabine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000271	CcSEcCtD
Capecitabine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00027	CcSEcCtD
Capecitabine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000101	0.000269	CcSEcCtD
Capecitabine—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000268	CcSEcCtD
Capecitabine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.0001	0.000268	CcSEcCtD
Capecitabine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000267	CcSEcCtD
Capecitabine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000267	CcSEcCtD
Capecitabine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000267	CcSEcCtD
Capecitabine—Infection—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000266	CcSEcCtD
Capecitabine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	9.98e-05	0.000266	CcSEcCtD
Capecitabine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	9.96e-05	0.000266	CcSEcCtD
Capecitabine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.000265	CcSEcCtD
Capecitabine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	9.94e-05	0.000265	CcSEcCtD
Capecitabine—Urticaria—Indinavir—acquired immunodeficiency syndrome	9.93e-05	0.000265	CcSEcCtD
Capecitabine—Shock—Saquinavir—acquired immunodeficiency syndrome	9.9e-05	0.000264	CcSEcCtD
Capecitabine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	9.89e-05	0.000264	CcSEcCtD
Capecitabine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	9.88e-05	0.000264	CcSEcCtD
Capecitabine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	9.88e-05	0.000264	CcSEcCtD
Capecitabine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	9.87e-05	0.000263	CcSEcCtD
Capecitabine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	9.86e-05	0.000263	CcSEcCtD
Capecitabine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	9.85e-05	0.000263	CcSEcCtD
Capecitabine—Vomiting—Stavudine—acquired immunodeficiency syndrome	9.83e-05	0.000262	CcSEcCtD
Capecitabine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	9.82e-05	0.000262	CcSEcCtD
Capecitabine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	9.79e-05	0.000261	CcSEcCtD
Capecitabine—Rash—Nelfinavir—acquired immunodeficiency syndrome	9.78e-05	0.000261	CcSEcCtD
Capecitabine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	9.77e-05	0.000261	CcSEcCtD
Capecitabine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	9.77e-05	0.000261	CcSEcCtD
Capecitabine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	9.77e-05	0.00026	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	9.76e-05	0.00026	CcSEcCtD
Capecitabine—Rash—Stavudine—acquired immunodeficiency syndrome	9.75e-05	0.00026	CcSEcCtD
Capecitabine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	9.74e-05	0.00026	CcSEcCtD
Capecitabine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	9.74e-05	0.00026	CcSEcCtD
Capecitabine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	9.73e-05	0.00026	CcSEcCtD
Capecitabine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	9.72e-05	0.000259	CcSEcCtD
Capecitabine—Headache—Nelfinavir—acquired immunodeficiency syndrome	9.72e-05	0.000259	CcSEcCtD
Capecitabine—Headache—Stavudine—acquired immunodeficiency syndrome	9.69e-05	0.000258	CcSEcCtD
Capecitabine—Vomiting—Abacavir—acquired immunodeficiency syndrome	9.69e-05	0.000258	CcSEcCtD
Capecitabine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	9.68e-05	0.000258	CcSEcCtD
Capecitabine—Pain—Delavirdine—acquired immunodeficiency syndrome	9.66e-05	0.000258	CcSEcCtD
Capecitabine—Constipation—Delavirdine—acquired immunodeficiency syndrome	9.66e-05	0.000258	CcSEcCtD
Capecitabine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	9.66e-05	0.000258	CcSEcCtD
Capecitabine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	9.65e-05	0.000257	CcSEcCtD
Capecitabine—Rash—Abacavir—acquired immunodeficiency syndrome	9.61e-05	0.000256	CcSEcCtD
Capecitabine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	9.6e-05	0.000256	CcSEcCtD
Capecitabine—Oedema—Lamivudine—acquired immunodeficiency syndrome	9.6e-05	0.000256	CcSEcCtD
Capecitabine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	9.59e-05	0.000256	CcSEcCtD
Capecitabine—Headache—Abacavir—acquired immunodeficiency syndrome	9.55e-05	0.000255	CcSEcCtD
Capecitabine—Infection—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000254	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	9.52e-05	0.000254	CcSEcCtD
Capecitabine—Nausea—Nevirapine—acquired immunodeficiency syndrome	9.52e-05	0.000254	CcSEcCtD
Capecitabine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	9.51e-05	0.000254	CcSEcCtD
Capecitabine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	9.45e-05	0.000252	CcSEcCtD
Capecitabine—Shock—Lamivudine—acquired immunodeficiency syndrome	9.44e-05	0.000252	CcSEcCtD
Capecitabine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	9.41e-05	0.000251	CcSEcCtD
Capecitabine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000251	CcSEcCtD
Capecitabine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	9.4e-05	0.000251	CcSEcCtD
Capecitabine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	9.38e-05	0.00025	CcSEcCtD
Capecitabine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	9.38e-05	0.00025	CcSEcCtD
Capecitabine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.000249	CcSEcCtD
Capecitabine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	9.34e-05	0.000249	CcSEcCtD
Capecitabine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	9.32e-05	0.000249	CcSEcCtD
Capecitabine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	9.32e-05	0.000248	CcSEcCtD
Capecitabine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	9.31e-05	0.000248	CcSEcCtD
Capecitabine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	9.28e-05	0.000247	CcSEcCtD
Capecitabine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	9.24e-05	0.000246	CcSEcCtD
Capecitabine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	9.22e-05	0.000246	CcSEcCtD
Capecitabine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	9.21e-05	0.000246	CcSEcCtD
Capecitabine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.000245	CcSEcCtD
Capecitabine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	9.2e-05	0.000245	CcSEcCtD
Capecitabine—Nausea—Stavudine—acquired immunodeficiency syndrome	9.19e-05	0.000245	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	9.17e-05	0.000244	CcSEcCtD
Capecitabine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	9.15e-05	0.000244	CcSEcCtD
Capecitabine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	9.1e-05	0.000243	CcSEcCtD
Capecitabine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	9.09e-05	0.000242	CcSEcCtD
Capecitabine—Nausea—Abacavir—acquired immunodeficiency syndrome	9.05e-05	0.000241	CcSEcCtD
Capecitabine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	9.03e-05	0.000241	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	9.02e-05	0.000241	CcSEcCtD
Capecitabine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	9.01e-05	0.00024	CcSEcCtD
Capecitabine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	8.98e-05	0.000239	CcSEcCtD
Capecitabine—Asthenia—Indinavir—acquired immunodeficiency syndrome	8.97e-05	0.000239	CcSEcCtD
Capecitabine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	8.97e-05	0.000239	CcSEcCtD
Capecitabine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.000239	CcSEcCtD
Capecitabine—Pain—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000238	CcSEcCtD
Capecitabine—Constipation—Ritonavir—acquired immunodeficiency syndrome	8.94e-05	0.000238	CcSEcCtD
Capecitabine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	8.93e-05	0.000238	CcSEcCtD
Capecitabine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	8.93e-05	0.000238	CcSEcCtD
Capecitabine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	8.89e-05	0.000237	CcSEcCtD
Capecitabine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	8.86e-05	0.000236	CcSEcCtD
Capecitabine—Pruritus—Indinavir—acquired immunodeficiency syndrome	8.85e-05	0.000236	CcSEcCtD
Capecitabine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	8.74e-05	0.000233	CcSEcCtD
Capecitabine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	8.74e-05	0.000233	CcSEcCtD
Capecitabine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	8.7e-05	0.000232	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	8.68e-05	0.000232	CcSEcCtD
Capecitabine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	8.68e-05	0.000231	CcSEcCtD
Capecitabine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	8.67e-05	0.000231	CcSEcCtD
Capecitabine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	8.62e-05	0.00023	CcSEcCtD
Capecitabine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	8.61e-05	0.00023	CcSEcCtD
Capecitabine—Constipation—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.000229	CcSEcCtD
Capecitabine—Pain—Saquinavir—acquired immunodeficiency syndrome	8.6e-05	0.000229	CcSEcCtD
Capecitabine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	8.56e-05	0.000228	CcSEcCtD
Capecitabine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	8.55e-05	0.000228	CcSEcCtD
Capecitabine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	8.55e-05	0.000228	CcSEcCtD
Capecitabine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	8.55e-05	0.000228	CcSEcCtD
Capecitabine—Rash—Zidovudine—acquired immunodeficiency syndrome	8.48e-05	0.000226	CcSEcCtD
Capecitabine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	8.48e-05	0.000226	CcSEcCtD
Capecitabine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	8.47e-05	0.000226	CcSEcCtD
Capecitabine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	8.45e-05	0.000225	CcSEcCtD
Capecitabine—Headache—Zidovudine—acquired immunodeficiency syndrome	8.42e-05	0.000225	CcSEcCtD
Capecitabine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	8.36e-05	0.000223	CcSEcCtD
Capecitabine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	8.34e-05	0.000222	CcSEcCtD
Capecitabine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	8.33e-05	0.000222	CcSEcCtD
Capecitabine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	8.3e-05	0.000221	CcSEcCtD
Capecitabine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	8.29e-05	0.000221	CcSEcCtD
Capecitabine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	8.29e-05	0.000221	CcSEcCtD
Capecitabine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	8.27e-05	0.000221	CcSEcCtD
Capecitabine—Dizziness—Indinavir—acquired immunodeficiency syndrome	8.27e-05	0.00022	CcSEcCtD
Capecitabine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	8.26e-05	0.00022	CcSEcCtD
Capecitabine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	8.26e-05	0.00022	CcSEcCtD
Capecitabine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	8.23e-05	0.000219	CcSEcCtD
Capecitabine—Constipation—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000219	CcSEcCtD
Capecitabine—Pain—Lamivudine—acquired immunodeficiency syndrome	8.21e-05	0.000219	CcSEcCtD
Capecitabine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	8.11e-05	0.000216	CcSEcCtD
Capecitabine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	8.08e-05	0.000216	CcSEcCtD
Capecitabine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	8e-05	0.000213	CcSEcCtD
Capecitabine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	7.99e-05	0.000213	CcSEcCtD
Capecitabine—Nausea—Zidovudine—acquired immunodeficiency syndrome	7.99e-05	0.000213	CcSEcCtD
Capecitabine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	7.95e-05	0.000212	CcSEcCtD
Capecitabine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	7.95e-05	0.000212	CcSEcCtD
Capecitabine—Vomiting—Indinavir—acquired immunodeficiency syndrome	7.95e-05	0.000212	CcSEcCtD
Capecitabine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	7.91e-05	0.000211	CcSEcCtD
Capecitabine—Rash—Indinavir—acquired immunodeficiency syndrome	7.88e-05	0.00021	CcSEcCtD
Capecitabine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	7.88e-05	0.00021	CcSEcCtD
Capecitabine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	7.85e-05	0.000209	CcSEcCtD
Capecitabine—Headache—Indinavir—acquired immunodeficiency syndrome	7.83e-05	0.000209	CcSEcCtD
Capecitabine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	7.81e-05	0.000208	CcSEcCtD
Capecitabine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	7.73e-05	0.000206	CcSEcCtD
Capecitabine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	7.7e-05	0.000205	CcSEcCtD
Capecitabine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	7.62e-05	0.000203	CcSEcCtD
Capecitabine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000202	CcSEcCtD
Capecitabine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	7.59e-05	0.000202	CcSEcCtD
Capecitabine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	7.51e-05	0.0002	CcSEcCtD
Capecitabine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	7.5e-05	0.0002	CcSEcCtD
Capecitabine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	7.47e-05	0.000199	CcSEcCtD
Capecitabine—Rash—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.000199	CcSEcCtD
Capecitabine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	7.44e-05	0.000198	CcSEcCtD
Capecitabine—Nausea—Indinavir—acquired immunodeficiency syndrome	7.43e-05	0.000198	CcSEcCtD
Capecitabine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	7.41e-05	0.000198	CcSEcCtD
Capecitabine—Headache—Efavirenz—acquired immunodeficiency syndrome	7.4e-05	0.000197	CcSEcCtD
Capecitabine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	7.39e-05	0.000197	CcSEcCtD
Capecitabine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	7.22e-05	0.000192	CcSEcCtD
Capecitabine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	7.19e-05	0.000192	CcSEcCtD
Capecitabine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	7.15e-05	0.000191	CcSEcCtD
Capecitabine—Rash—Delavirdine—acquired immunodeficiency syndrome	7.13e-05	0.00019	CcSEcCtD
Capecitabine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	7.12e-05	0.00019	CcSEcCtD
Capecitabine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	7.12e-05	0.00019	CcSEcCtD
Capecitabine—Headache—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.000189	CcSEcCtD
Capecitabine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	7.07e-05	0.000189	CcSEcCtD
Capecitabine—Nausea—Efavirenz—acquired immunodeficiency syndrome	7.02e-05	0.000187	CcSEcCtD
Capecitabine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	6.91e-05	0.000184	CcSEcCtD
Capecitabine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	6.89e-05	0.000184	CcSEcCtD
Capecitabine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	6.88e-05	0.000184	CcSEcCtD
Capecitabine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	6.79e-05	0.000181	CcSEcCtD
Capecitabine—Nausea—Delavirdine—acquired immunodeficiency syndrome	6.71e-05	0.000179	CcSEcCtD
Capecitabine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	6.65e-05	0.000177	CcSEcCtD
Capecitabine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	6.65e-05	0.000177	CcSEcCtD
Capecitabine—Rash—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000176	CcSEcCtD
Capecitabine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	6.58e-05	0.000176	CcSEcCtD
Capecitabine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	6.57e-05	0.000175	CcSEcCtD
Capecitabine—Headache—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000175	CcSEcCtD
Capecitabine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	6.4e-05	0.000171	CcSEcCtD
Capecitabine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000169	CcSEcCtD
Capecitabine—Rash—Saquinavir—acquired immunodeficiency syndrome	6.34e-05	0.000169	CcSEcCtD
Capecitabine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	6.34e-05	0.000169	CcSEcCtD
Capecitabine—Headache—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000168	CcSEcCtD
Capecitabine—Nausea—Ritonavir—acquired immunodeficiency syndrome	6.21e-05	0.000166	CcSEcCtD
Capecitabine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	6.1e-05	0.000163	CcSEcCtD
Capecitabine—Rash—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000161	CcSEcCtD
Capecitabine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	6.05e-05	0.000161	CcSEcCtD
Capecitabine—Headache—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.00016	CcSEcCtD
Capecitabine—Nausea—Saquinavir—acquired immunodeficiency syndrome	5.98e-05	0.000159	CcSEcCtD
Capecitabine—Nausea—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.000152	CcSEcCtD
